1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Antagonistic cannabinoid CB1-dopamine D2 receptor interactions in striatal CB1-D2 heteromers - A com

Antagonistic cannabinoid CB1-dopamine D2 receptor interactions in striatal CB1-D2 heteromers - A com

  1. Jasim
    In vitro results show the ability of the CB1 receptor agonist CP 55,940 to reduce the affinity of D2 receptor agonist binding sites in both the
    dorsal and ventral striatum including the nucleus accumbens shell. This antagonistic modulation of D2 receptor agonist affinity was found to
    remain and even be enhanced after G-protein activation by Gpp(NH)p. Using the FRET technique in living HEK-293T cells, the formation
    of CB1eD2 receptor heteromers, independent of receptor occupancy, was demonstrated. These data thereby indicate that the antagonistic
    intramembrane CB1/D2 receptorereceptor interactions may occur in CB1/D2 formed heteromers. Antagonistic CB1/D2 interactions were also discovered at the behavioral level through an analysis of quinpirole-induced locomotor hyperactivity in rats. The CB1 receptor agonist CP 55,940 at a dose that did not change basal locomotion was able to block quinpirole-induced increases in locomotor activity. In addition, not
    only the CB1 receptor antagonist rimonobant but also the specific A2A receptor antagonist MSX-3 blocked the inhibitory effect of CB1 receptor
    agonist on D2-like receptor agonist-induced hyperlocomotion. Taken together, these results give evidence for the existence of antagonistic CB1/D2 receptor-receptor interactions within CB1/D2 heteromers in which A2A receptors may also participate.
Tags: